Evidence map›Paper›PMID 33855014›Full record

ArticleFrontiers in bioengineering and biotechnology2021

Comparison Between a Standard and SalivaDirect RNA Extraction Protocol for Molecular Diagnosis of SARS-CoV-2 Using Nasopharyngeal Swab and Saliva Clinical Samples.

Sofía N Rodríguez Flores, Luis Mario Rodríguez-Martínez, Bernardita L Reyes-Berrones, Nadia A Fernández-Santos, Elthon J Sierra-Moncada, Mario A Rodríguez-Pérez

Open access · goldAbstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.1field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Scalable solutions for global health: the SalivaDirect model.Frontiers in cellular and infection microbiology · 2024
    Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Sofía N Rodríguez FloresInstituto Politécnico Nacional, Centro de Biotecnologia Genomica, Reynosa, Mexico.
Luis Mario Rodríguez-MartínezInstituto Politécnico Nacional, Centro de Biotecnologia Genomica, Reynosa, Mexico.
Bernardita L Reyes-BerronesLaboratorio Estatal de Salud Pública de Tamaulipas, Secretaría de Salud de Tamaulipas, Ciudad Victoria, Mexico.
Nadia A Fernández-SantosInstituto Politécnico Nacional, Centro de Biotecnologia Genomica, Reynosa, Mexico.
Elthon J Sierra-MoncadaUniversidad Autónoma de Nuevo León, Facultad de Ingeniería Mecánica y Eléctrica, San Nicolás de los Garza, Mexico.
Mario A Rodríguez-PérezInstituto Politécnico Nacional, Centro de Biotecnologia Genomica, Reynosa, Mexico.
Instituto Politécnico Nacional · MXSecretaria de Salud · MXUniversidad Autónoma de Nuevo León · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

During the COVID-19 pandemic, a certified laboratory of Tamaulipas, Mexico has processed over 100,000 samples of COVID-19 suspected patients, working a minimum of 100 tests daily. Thus, it would be beneficial for such certified laboratories nationwide to reduce the time and cost involved in performing the diagnosis of COVID-19, from sample collection, transportation to local lab, processing of samples, and data acquisition. Here, 30 nasopharyngeal swab and saliva samples from the same COVID-19 individuals were assessed by a standard nucleic acid extraction protocol, including protein lysis with proteinase K followed by binding to column, washing, and elution, and by the SalivaDirect protocol based on protein lysis, skipping the other steps to reduce processing time and costs. The genomic RNA was amplified using a SARS-CoV-2 Real-Time PCR kit. A variation (

Indexed as

clinical samplesCOVID-19molecular diagnosisRNA extraction protocolSARS-CoV-2

Identifiers

PMID33855014
PMCPMC8040950
OpenAlexW3146376539

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.